Regen BioPharma, Inc.
RGBP
$0.01
$0.0020.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.27M | -972.80K | -935.60K | -1.04M | -668.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 52.00K | -24.20K | -12.50K | -20.80K | -29.00K |
| Total Other Non-Cash Items | 803.60K | 677.50K | 205.30K | 205.30K | 200.10K |
| Change in Net Operating Assets | 35.20K | -111.40K | 195.30K | 198.60K | -254.40K |
| Cash from Operations | -383.60K | -430.90K | -547.50K | -655.60K | -751.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 344.30K | 302.20K | 246.20K | 143.30K | 77.50K |
| Total Debt Repaid | -- | 40.50K | 61.50K | 36.50K | -10.00K |
| Issuance of Common Stock | 58.20K | 28.20K | 163.50K | 351.40K | 563.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.00K | -- | -- | -- | -- |
| Cash from Financing | 452.50K | 370.90K | 471.20K | 531.20K | 631.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 68.80K | -60.10K | -76.40K | -124.40K | -120.30K |